EU drug regulator recommends clearing vaccine for monkeypox

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"1">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>The European Medicines Agency has said the smallpox vaccine made by Bavarian Nordic should also be authorised against monkeypox&comma; as the outbreak of the once-rare disease continues to affect people across the continent&period;<&sol;p>&NewLine;<p>The European Union drug regulator said its recommendation was based on animal studies that suggest the vaccine protects non-human primates from monkeypox&period; It is up to the EU’s executive arm&comma; the European Commission&comma; to approve the vaccine formally based on the EMA’s recommendation&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;To confirm the effectiveness of the vaccine against monkeypox&comma; the company will collect data from an observational study that will be carried out during the ongoing monkeypox outbreak in Europe&comma;” the EMA said&period;<&sol;p>&NewLine;<p>It added that the vaccine’s safety profile was &OpenCurlyDoubleQuote;favourable” and the benefits of its use during the ongoing monkeypox outbreak outweighed the risks&comma; noting mostly mild to moderate side effects&period;<&sol;p>&NewLine;<p>The vaccine&comma; known as Imvanex in Europe but sold as Jynneos in the United States&comma; was already cleared for use against monkeypox by American regulators&period;<&sol;p>&NewLine;<p>Of the more than 15&comma;000 monkeypox cases reported worldwide&comma; nearly 70&percnt; are in Europe&comma; with more than 30 countries across the continent affected&period;<&sol;p>&NewLine;<p>Doses of the Bavarian Nordic vaccine are extremely limited&period; Most of the world’s supply has already been bought by countries and regions including Britain&comma; Canada&comma; the EU and the US&period;<&sol;p>&NewLine;<p>None has gone to Africa&comma; where a more severe version of monkeypox has killed dozens of people&period; No monkeypox deaths have been reported in richer countries&period;<&sol;p>&NewLine;<p>People who catch monkeypox often experience symptoms that include fever&comma; body aches&comma; a rash and lesions&semi; most recover within weeks without needing medical attention&period;<&sol;p>&NewLine;<p>Authorities in numerous countries&comma; including Britain&comma; Germany and the US&comma; have offered the vaccine to health workers and those at high risk of being infected by monkeypox&period;<&sol;p>&NewLine;<p>In the US&comma; soaring demand for the vaccine caused the appointment system to crash in New York City&comma; one of many places where supplies have run out almost immediately after they arrived&period;<&sol;p>&NewLine;<p>The World Health Organisation is deciding whether or not to declare the outbreak to be a global emergency&comma; after convening its experts for a meeting on Thursday&period;<&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68eceb6e74814">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68eceb6e74814'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version